Beth Hecht - 29 Jan 2022 Form 4 Insider Report for Xeris Biopharma Holdings, Inc. (XERS)

Signature
/s/ Beth Hecht
Issuer symbol
XERS
Transactions as of
29 Jan 2022
Net transactions value
-$350,650
Form type
4
Filing time
09 Aug 2024, 16:07:16 UTC
Previous filing
05 Jan 2022
Next filing
22 Mar 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XERS Common Stock Tax liability $29,618 -14,037 -0.9% $2.11* 1,544,771 29 Jan 2022 Direct F1, F2, F3
transaction XERS Common Stock Tax liability $9,385 -4,448 -0.29% $2.11* 1,540,323 31 Jan 2022 Direct F1, F4
transaction XERS Common Stock Tax liability $37,507 -33,488 -2.2% $1.12 1,506,835 03 Jan 2023 Direct F1, F5
transaction XERS Common Stock Tax liability $26,683 -21,177 -1.4% $1.26 1,485,658 29 Jan 2023 Direct F1, F6
transaction XERS Common Stock Tax liability $7,172 -5,784 -0.39% $1.24 1,479,874 31 Jan 2023 Direct F1, F7
transaction XERS Common Stock Tax liability $75,013 -33,488 -2.3% $2.24 1,446,386 03 Jan 2024 Direct F1, F8
transaction XERS Common Stock Tax liability $52,336 -19,675 -1.4% $2.66 1,426,711 29 Jan 2024 Direct F1, F9
transaction XERS Common Stock Tax liability $112,936 -45,909 -3.2% $2.46 1,380,802 31 Jan 2024 Direct F1, F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction is being reported late due to administrative oversight.
F2 Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 29, 2022.
F3 These shares include 3,840 shares that were purchased on June 30, 2024 due to participation by the reporting individual in the issuer's 2018 Employee Stock Purchase Plan.
F4 Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 31, 2022.
F5 Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 3, 2023.
F6 Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 29, 2023.
F7 Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 31, 2023.
F8 Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 3, 2024.
F9 Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 29, 2024.
F10 Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 31, 2024.

Remarks:

Chief Legal Officer and Corporate Secretary